Cellular tumor antigen p53 (TP53) N-terminal transactivation domain (TP53 TAD)

The TP53 N-terminal regulatory region, primarily consisting of the transactivation domain (TAD), is a vital segment of the p53 tumor suppressor protein responsible for mediating its transcriptional activity. This region, which includes residues 1–61, acts as a scaffold for recruiting co-activators and the basal transcription machinery, enabling p53 to regulate genes involved in cell cycle arrest, DNA repair, and apoptosis (UniProt P04637). It is also the primary site for interaction with negative regulators such as MDM2 and MDMX, which bind to the N-terminus to inhibit p53 function and promote its degradation (PMID: 25210018). In many cancers where p53 remains wild-type, its activity is often suppressed by MDM2 overexpression, making the p53-MDM2 interface a high-priority therapeutic target. Small-molecule inhibitors like Idasanutlin and Navtemadlin are designed to disrupt this interaction by mimicking the p53 N-terminal residues, thereby stabilizing p53 and restoring its tumor-suppressive capabilities (PMID: 30104365). While promising, these therapies are often limited by hematological toxicities and are generally effective only in patients with wild-type TP53 (PMID: 33009416).

Other names

p53 N-terminal domainp53 transactivation domainp53 TADp53 N-terminal regulatory regionTumor protein p53 N-terminus

Restoration of p53 activity by inhibiting the protein-protein interaction between the p53 N-terminal transactivation domain and the E3 ubiquitin ligase MDM2.